Search Results

There are 5452 results for: content related to: Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

  1. You have free access to this content
    Ropinirole, a Non-Ergoline Dopamine Agonist

    CNS Drug Reviews

    Volume 11, Issue 3, September 2005, Pages: 253–272, Wolfgang H. Jost and Dieter Angersbach

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2005.tb00046.x

  2. PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1259–1265, Fabrizio Stocchi, Luigi Giorgi, Brian Hunter and Anthony HV Schapira

    Version of Record online : 5 APR 2011, DOI: 10.1002/mds.23498

  3. You have free access to this content
    Comparison of ropinirole controlled- and immediate-release in Japanese patients with advanced Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 1, January 2015, Pages: 18–24, Nobutaka Hattori, Hiroshi Nishioka, Kazuko Hasegawa and on behalf of the SWAN Study Investigators

    Version of Record online : 25 NOV 2014, DOI: 10.1111/ncn3.128

  4. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  5. Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson’s disease

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 571–577, N. Hattori, K. Hasegawa and T. Sakamoto

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01336.x

  6. You have free access to this content
    D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways

    FEBS Letters

    Volume 582, Issue 5, March 05, 2008, Pages: 603–610, Sheng Chen, Xiaojie Zhang, Dehua Yang, Yunlan Du, Liang Li, Xuping Li, Ming Ming and Weidong Le

    Version of Record online : 31 JAN 2008, DOI: 10.1016/j.febslet.2008.01.028

  7. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001517

  8. DA agonists - Non-Ergot derivaties: Ropinirole

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S98–S102,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5570

  9. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease

    Movement Disorders

    Volume 24, Issue 14, 30 October 2009, Pages: 2121–2127, Kelly E. Lyons and Rajesh Pahwa

    Version of Record online : 18 SEP 2009, DOI: 10.1002/mds.22750

  10. Ropinirole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine HO Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001516

  11. Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L-Dopa in Patients with Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 2, February 1999, Pages: 150–156, Dr. Anne C. Taylor, Dr. Almisbah Beerahee, Dr. David R. Citerone, Dr. Matthew J. Cyronak, Dr. Terry J. Leigh, Dr. Katherine L. Fitzpatrick, Dr. Arturo Lopez-Gil, Dr. Sarosh D. Vakil, Dr. Eileen Burns and Dr. Graham Lennox

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.

  12. Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1627–1635, Jacques Montplaisir, Jeff Karrasch, Jean Haan and Dieter Volc

    Version of Record online : 27 JUL 2006, DOI: 10.1002/mds.21050

  13. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  14. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

    Movement Disorders

    Volume 13, Issue 1, January 1998, Pages: 46–51, Prof. Amos D. Korczyn, David J. Brooks, Ehrout R. Brunt, Warner H. Poewe, Olivier Rascol and Fabrizzio Stocchi

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130112

  15. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  16. Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

    Movement Disorders

    Volume 21, Issue 11, November 2006, Pages: 1844–1850, Olivier Rascol, David J. Brooks, Amos D. Korczyn, Peter P. De Deyn, Carl E. Clarke, Anthony E. Lang and Mona Abdalla

    Version of Record online : 6 SEP 2006, DOI: 10.1002/mds.20988

  17. Preparation and biological evaluation of 99mTc–ropinirole as a novel radiopharmaceutical for brain imaging

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 59, Issue 4, April 2016, Pages: 147–152, M. A. Motaleb, I. T. Ibrahem, V. R. Ayoub and A. S. Geneidi

    Version of Record online : 23 FEB 2016, DOI: 10.1002/jlcr.3380

  18. You have free access to this content
    The weight of evidence for ropinirole in restless legs syndrome

    European Journal of Neurology

    Volume 13, Issue s2, September 2006, Pages: 21–30, C. Trenkwalder

    Version of Record online : 15 AUG 2006, DOI: 10.1111/j.1468-1331.2006.01588.x

  19. You have free access to this content
    Interactions between domperidone and ropinirole, a novel dopamine D2- receptor agonist.

    British Journal of Clinical Pharmacology

    Volume 32, Issue 4, October 1991, Pages: 483–488, C de Mey, D Enterling, I Meineke and S Yeulet

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1991.tb03935.x

  20. A single and multiple dose study to investigate the pharmacokinetics of a prolonged release formulation of ropinirole in healthy Chinese subjects

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 84–92, Hongzhong Liu, Ji Jiang, Hongyun Wang, Xia Chen, Tao Liu, Haijun Cao, Jonathan Palmer, Anita Gu and Pei Hu

    Version of Record online : 30 OCT 2013, DOI: 10.1002/cpdd.28